Live Breaking News & Updates on Karl Andrew Leblanc

Stay updated with breaking news from Karl andrew leblanc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces Secondary Endpoint Achieved in nanoMesh™ Pathogen Inhibiting Protein (PIP) Uptake Studies


nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces Secondary Endpoint Achieved in nanoMesh™ Pathogen Inhibiting Protein (PIP) Uptake Studies
nanoMesh™, An Innovative Soft Tissue Repair Implant Possesses A Unique Nanometer-level Surface Texture
News provided by
Share this article
Share this article
BILLERICA, Mass., June 9, 2021 /PRNewswire/ nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today that it has successfully achieved the secondary endpoints for the nanoMesh™ Pathogen Inhibiting Protein (PIP) uptake studies. The PIP trials demonstrated controlled uptake
[1] of a series of pathogen inhibiting, tissue integrating enhancing, and scar formation inhibition proteins
[2], including fibronectin
[6] and laminin
[7] by nanoMesh™. nanoMesh™ possesses a unique nanometer-level surface texture, via the application of Accelerated Neutral Atom Beam (ANAB) technology ....

United States , Karl Andrew Leblanc , Karla Leblanc , American Society Of Metabolic , Drug Administration , Society For Laparoendoscopic Surgeons , Society Of American Gastrointestinal , Americas Hernia Society , Master Of Business Administration , Exogenesis Corporation , American College Of Surgeons , Exogenesis Corporation Completed First , School In Shreveport , Pathogen Inhibiting Protein , Accelerated Neutral Atom Beam , Business Administration , Board Certified , American College , American Society , Bariatric Surgery , Laparoendoscopic Surgeons , American Gastrointestinal , Endoscopic Surgeons , Master Surgeon , Laparoscopic Surgery , Minimally Invasive Surgery Fellowship ,